Gene · 4055
Papers3,299
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,299
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The chemorepellent, SLIT2, bolsters innate immunity against Staphylococcus aureus. | Elife | 2023 | 37773612 | PubTator, text mining | PubMed |
| Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension. | ESC Heart Fail | 2023 | 37772417 | PubTator, text mining | PubMed |
| Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target. | Viruses | 2023 | 37766319 | PubTator, text mining | PubMed |
| Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy. | Life (Basel) | 2023 | 37763265 | PubTator, text mining | PubMed |
| Modulation of Skin Cancer by the Stimulator of Interferon Genes. | Genes (Basel) | 2023 | 37761934 | PubTator, text mining | PubMed |
| Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential. | Cardiovasc Diabetol | 2023 | 37749569 | PubTator, text mining | PubMed |
| Inflammation-related signaling pathways in tendinopathy. | Open Life Sci | 2023 | 37744452 | PubTator, text mining | PubMed |
| Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. | PeerJ | 2023 | 37744234 | PubTator, text mining | PubMed |
| Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. | EBioMedicine | 2023 | 37741009 | PubTator, text mining | PubMed |
| Proteomic architecture of frailty across the spectrum of cardiovascular disease. | Aging Cell | 2023 | 37731195 | PubTator, text mining | PubMed |
| Tendon tissue engineering: An overview of biologics to promote tendon healing and repair. | J Tissue Eng | 2023 | 37719308 | PubTator, text mining | PubMed |
| Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer. | Front Immunol | 2023 | 37711621 | PubTator, text mining | PubMed |
| Marine Natural Compound (Neviotin A) Displays Anticancer Efficacy by Triggering Transcriptomic Alterations and Cell Death in MCF-7 Cells. | Molecules | 2023 | 37687120 | PubTator, text mining | PubMed |
| The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications. | Mol Cancer | 2023 | 37679744 | PubTator, text mining | PubMed |
| The benefits of clustering in TNF receptor superfamily signaling. | Front Immunol | 2023 | 37662920 | PubTator, text mining | PubMed |
| Role and regulatory mechanism of microRNA mediated neuroinflammation in neuronal system diseases. | Front Immunol | 2023 | 37637999 | PubTator, text mining | PubMed |
| Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis. | Int J Mol Sci | 2023 | 37629097 | PubTator, text mining | PubMed |
| Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma. | Int J Mol Sci | 2023 | 37628907 | PubTator, text mining | PubMed |
| Mechanism Analysis of Vascular Calcification Based on Fluid Dynamics. | Diagnostics (Basel) | 2023 | 37627891 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer. | Front Immunol | 2023 | 37622111 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4055/papers?page=10